Anyone involved in the transfusion chain is required to submit reports, because Art. 59 TPA specifies both the manufacturer or distributor of blood and blood products (blood transfusion services) and all professionals who use labile blood products or are entitled to do so (doctors, nurses or laboratory professionals).
Reports are usually submitted to the RPHv. The various parties involved exchange information to gain as full a picture as possible of the case and pass on their findings to the RPHv. Once the clinical and diagnostic investigations have been completed, the RPHv sends the report to Swissmedic and the blood transfusion service.
Doctors’ practices which occasionally use blood and labile blood products can send their reports to the blood transfusion centre or directly to Swissmedic.